Unione Europea - italiano - EMA (European Medicines Agency)

sanofi b.v. - tireotropina alfa - neoplasie della tiroide - dell'ipofisi anteriore del lobo ormoni e farmaceutici, l'ipofisi e l'ipotalamo gli ormoni e farmaceutici - thyrogen is indicated for use with serum thyroglobulin (tg) testing with or without radioiodine imaging for the detection of thyroid remnants and well-differentiated thyroid cancer in post thyroidectomy patients maintained on hormone suppression therapy (thst). low risk patients with well-differentiated thyroid carcinoma who have undetectable serum tg levels on thst and no rh (recombinant human) tsh-stimulated increase of tg levels may be followed-up by assaying rh tsh-stimulated tg levels. thyrogen is indicated for pre-therapeutic stimulation in combination with a range of 30 mci (1. 1 gbq) to 100 mci (3. 7 gbq) radioiodine for ablation of thyroid tissue remnants in patients who have undergone a near-total or total thyroidectomy for well-differentiated thyroid cancer and who do not have evidence of distant metastatic thyroid cancer (see section 4.

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

sanofi-aventis (suisse) sa - thyrotropinum alfa - poudre versare soluzione iniettabile - praeparatio cryodesiccata: thyrotropinum alfa 0.9 mg, mannitolum, natrii dihydrogenophosphas monohydricus, dinatrii phosphas heptahydricus, natrii chloridum, pro vitro corresp. natrium 1.19 mg. - il cancro della tiroide - biotechnologika

Italia - italiano - Ministero della Salute

le vet beheer b.v. - levothyroxine sodio - levothyroxine sodio - 600 mcg - levothyroxine sodium

Italia - italiano - Ministero della Salute

le vet beheer b.v. - levothyroxine sodio - levothyroxine sodio - 200 mcg - levothyroxine sodium

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

merck (schweiz) ag - levothyroxinum natricum anhydricum, liothyroninum natricum - compresse - levothyroxinum natricum anhydricum 0.100 mg come levothyroxinum natricum, liothyroninum natricum 0,020 mg, lactosum monohydricum 65.880 mg, maydis per amylum, gelatina, carmellosum natricum solo tenuti insieme, magnesio stearas per compresso corrisp. sodio 309 µg. - euthyreote gozzo, ipotiroidismo; come adiuvante per un un farmaco della tiroide in caso di ipertiroidismo - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

ibsa institut biochimique sa - levothyroxinum natricum - capsula molle - levothyroxinum natricum 25 µg, gelatina hydrolysata, gelatina, glycerolum, aqua purificata, pro capsula corresp. natrium max. 0.005 mg. - ipotiroidismo - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

ibsa institut biochimique sa - levothyroxinum natricum - capsula molle - levothyroxinum natricum 50 µg, gelatina hydrolysata, gelatina, glycerolum, aqua purificata, pro capsula corresp. natrium max. 0.005 mg. - ipotiroidismo - synthetika

Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

ibsa institut biochimique sa - levothyroxinum natricum - capsula molle - levothyroxinum natricum 75 µg, gelatina hydrolysata, gelatina, glycerolum, aqua purificata, pro capsula corresp. natrium max. 0.005 mg. - ipotiroidismo - synthetika